Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2/3 1

Status

Completed 46Unknown 34Terminated 8Recruiting 5Active not recruiting 5Withdrawn 3Not yet recruiting 3Suspended 1

Sponsor Class

OTHER 5

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Gastrointestinal 5Gynecologic 2Tumor-Agnostic 1Head & Neck 1Breast 1

Conditions

Carcinoma, Hepatocellular 3Multi-organ Metastatic Colorectal Cancer 1Cholangiocarcinoma 1

Interventions

Oxaliplatin 95Fluorouracil 84Capecitabine 75Gemcitabine 72Leucovorin 68Nivolumab 67Bevacizumab 63pembrolizumab 60Magnetic Resonance Spectroscopy 52Specimen Handling 50Irinotecan 50durvalumab 46Radiotherapy 42atezolizumab 40Cisplatin 39Paclitaxel 37Biopsy 37130-nm albumin-bound paclitaxel 34Cetuximab 30Carboplatin 27Albumin-Bound Paclitaxel 26Taxes 24Drug Therapy 20dehydroftorafur 19Radiation 19Ipilimumab 19tislelizumab 18Surgical Procedures, Operative 17Standard of Care 17Docetaxel 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Active not recruiting × Radiofrequency Ablation × Gastrointestinal × Clear all
NCT05666271 2026-04-13

Radiofrequency Ablation for Hepatocellular Carcinoma Using Octopus MP Electrodes

Seoul National University Hospital

Active not recruiting
76 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT01792934 2025-04-15

ORCHESTRA

Radboud University Medical Center

Phase NA Active not recruiting
478 enrolled
Gastrointestinal

Multi-organ Metastatic Colorectal Cancer

NCT06682377 2024-11-12

SM-OCT-01

Seoul National University Hospital

Phase NA Active not recruiting
159 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT05433701 2023-08-18

Stereotactic Body Radiotherapy Versus Radiofrequency Ablation for Unresectable, Small (≤ 3 cm) HCC

Asan Medical Center

Phase NA Active not recruiting
178 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT02482454 2017-08-01

Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cholangiocarcinoma

The First People's Hospital of Changzhou

Phase 2/3 Active not recruiting
50 enrolled
Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡